These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26613636)

  • 21. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
    Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
    Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
    Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
    Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.
    Chawarski MC; Mazlan M; Schottenfeld RS
    Drug Alcohol Depend; 2008 Apr; 94(1-3):281-4. PubMed ID: 18164145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
    Groshkova T; Metrebian N; Hallam C; Charles V; Martin A; Forzisi L; Lintzeris N; Strang J
    Drug Alcohol Rev; 2013 Nov; 32(6):566-73. PubMed ID: 24118500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.
    Riksheim M; Gossop M; Clausen T
    J Subst Abuse Treat; 2014 Mar; 46(3):291-4. PubMed ID: 24210532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance.
    Caplehorn J; Deeks JJ
    Drug Alcohol Rev; 2006 Mar; 25(2):157-60. PubMed ID: 16627305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment.
    Branstetter SA; Bower EH; Kamien J; Amass L
    J Subst Abuse Treat; 2008 Mar; 34(2):208-14. PubMed ID: 17596905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release.
    Kinlock TW; Gordon MS; Schwartz RP; O'Grady K; Fitzgerald TT; Wilson M
    Drug Alcohol Depend; 2007 Dec; 91(2-3):220-7. PubMed ID: 17628351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study.
    Abrahamsson T; Widinghoff C; Lilliebladh A; Gedeon C; Nilvall K; Hakansson A
    Subst Abus; 2016; 37(1):104-9. PubMed ID: 26176490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.
    Moore BA; Fiellin DA; Barry DT; Sullivan LE; Chawarski MC; O'Connor PG; Schottenfeld RS
    J Gen Intern Med; 2007 Apr; 22(4):527-30. PubMed ID: 17372805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program.
    Bachhuber MA; Thompson C; Prybylowski A; Benitez J; Mazzella S; Barclay D
    Subst Abus; 2018; 39(2):167-172. PubMed ID: 29474119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.
    Kakko J; Svanborg KD; Kreek MJ; Heilig M
    Lancet; 2003 Feb; 361(9358):662-8. PubMed ID: 12606177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot randomized trial of exercise as adjunct therapy in a heroin-assisted treatment setting.
    Colledge F; Vogel M; Dürsteler-Macfarland K; Strom J; Schoen S; Pühse U; Gerber M
    J Subst Abuse Treat; 2017 May; 76():49-57. PubMed ID: 28143679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.